Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs NexLife

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and NexLife head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 263 · Grade C

NexLife

Visit NexLife Full brief →

FDA warning letter, June 2026 — issued to Nexlife Inc. dba Nexlife. See the FDA's warning letter database.

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 65 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make NexLife a bad call — it's best for readers comparing cash-pay compounded programs who understand the price-change rules and the limited scope of the refund promise. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
58
Supply Reliability
95
75
Transparency
90
72
Access Breadth
93
50
Clinical Oversight
92
82
Track Record
88
51
CoreAge RxBrief Score 94 · 65NexLife

Price, coverage & the tracker

CoreAge RxNexLife
Brief Score94/100 (A)65/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

$139/month advertised

Compounded semaglutide; all-dose marketing remains subject to price-change terms.

Confirm selected plan and refill schedule; six-month guarantee excludes medication costs.

Cancellation takes 30 days; another shipment and charge may occur unless medically waived.

Full price details

$139/month advertised for compounded semaglutide; all-dose marketing subject to price-change terms; selected plan and refill schedule require confirmation

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

$169/month advertised

Compounded tirzepatide; all-dose marketing remains subject to price-change terms.

Confirm selected plan and refill schedule; six-month guarantee excludes medication costs.

Cancellation takes 30 days; another shipment and charge may occur unless medically waived.

Full price details

$169/month advertised for compounded tirzepatide; all-dose marketing subject to price-change terms; selected plan and refill schedule require confirmation

CoverageUS only; restrictions by state, confirmed at intakeAvailable only where affiliated clinicians and pharmacies can serve the patient; complete current eligible-state list unconfirmed.
Brand-name accessNot confirmedNot confirmed
Oral / sublingualInjection onlyUnconfirmed
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

NexLife: Cancellation normally takes 30 days and may include another shipment and charge. The six-month guarantee excludes medication costs.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.